Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Jul 1;160(1):341–346. doi: 10.1084/jem.160.1.341

Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain

PMCID: PMC2187422  PMID: 6736871

Abstract

In vitro killing of the human Daudi cell line by either univalent [F(ab')] or divalent (IgG) forms of rabbit anti-human Ig (RAHIg) coupled to ricin A chain can be specifically potentiated by a "piggyback" treatment with ricin B chain coupled to goat anti-rabbit Ig (GARIg). When cells are treated with univalent immunotoxin (IT) [F(ab') RAHIg-A] and then cultured, IT can be detected on the cell surface for at least 5 h, since GARIg-B can still enhance killing at this time. These results provide a strategy for in vivo use of A chain- and B chain-containing IT.

Full Text

The Full Text of this article is available as a PDF (372.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achord D. T., Brot F. E., Bell C. E., Sly W. S. Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells. Cell. 1978 Sep;15(1):269–278. doi: 10.1016/0092-8674(78)90102-2. [DOI] [PubMed] [Google Scholar]
  2. Fanger M. W., Hart D. A., Wells J. V., Nisonoff A. Requirement for cross-linkage in the stimulation of transformation of rabbit peripheral lymphocytes by antiglobulin reagents. J Immunol. 1970 Dec;105(6):1484–1492. [PubMed] [Google Scholar]
  3. Jansen F. K., Blythman H. E., Carrière D., Casellas P., Gros O., Gros P., Laurent J. C., Paolucci F., Pau B., Poncelet P. Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity. Immunol Rev. 1982;62:185–216. doi: 10.1111/j.1600-065x.1982.tb00394.x. [DOI] [PubMed] [Google Scholar]
  4. Masuho Y., Hara T. Target-cell cytotoxicity of a hybrid of Fab' on immunoglobulin and A-chain of ricin. Gan. 1980 Dec;71(6):759–765. [PubMed] [Google Scholar]
  5. Merril C. R., Goldman D., Sedman S. A., Ebert M. H. Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science. 1981 Mar 27;211(4489):1437–1438. doi: 10.1126/science.6162199. [DOI] [PubMed] [Google Scholar]
  6. Miyazaki H., Beppu M., Terao T., Osawa T. Preparation of antibody (IgG)-ricin A-chain conjugate and its biologic activity. Gan. 1980 Dec;71(6):766–774. [PubMed] [Google Scholar]
  7. Muirhead M., Martin P. J., Torok-Storb B., Uhr J. W., Vitetta E. S. Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow. Blood. 1983 Aug;62(2):327–332. [PubMed] [Google Scholar]
  8. Neville D. M., Jr, Youle R. J. Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy. Immunol Rev. 1982;62:75–91. doi: 10.1111/j.1600-065x.1982.tb00390.x. [DOI] [PubMed] [Google Scholar]
  9. Olsnes S., Pihl A. Chimeric toxins. Pharmacol Ther. 1981;15(3):355–381. doi: 10.1016/0163-7258(81)90050-4. [DOI] [PubMed] [Google Scholar]
  10. Raso V. Antibody mediated delivery of toxic molecules to antigen bearing target cells. Immunol Rev. 1982;62:93–117. doi: 10.1111/j.1600-065x.1982.tb00391.x. [DOI] [PubMed] [Google Scholar]
  11. Raso V., Griffin T. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate. J Immunol. 1980 Dec;125(6):2610–2616. [PubMed] [Google Scholar]
  12. SPIEGELBERG H. L., WEIGLE W. O. THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS. J Exp Med. 1965 Mar 1;121:323–338. doi: 10.1084/jem.121.3.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Thorpe P. E., Ross W. C. The preparation and cytotoxic properties of antibody-toxin conjugates. Immunol Rev. 1982;62:119–158. doi: 10.1111/j.1600-065x.1982.tb00392.x. [DOI] [PubMed] [Google Scholar]
  14. Vitetta E. S., Cushley W., Uhr J. W. Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6332–6335. doi: 10.1073/pnas.80.20.6332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Vitetta E. S., Krolick K. A., Miyama-Inaba M., Cushley W., Uhr J. W. Immunotoxins: a new approach to cancer therapy. Science. 1983 Feb 11;219(4585):644–650. doi: 10.1126/science.6218613. [DOI] [PubMed] [Google Scholar]
  16. Vitetta E. S., Krolick K. A., Uhr J. W. Neoplastic B cells as targets for antibody-ricin A chain immunotoxins. Immunol Rev. 1982;62:159–183. doi: 10.1111/j.1600-065x.1982.tb00393.x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES